Stage 0 Hypopharyngeal Carcinoma AJCC v8: Clinical Trials

1 trial for Stage 0 Hypopharyngeal Carcinoma AJCC v8, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow Stage 0 Hypopharyngeal Carcinoma AJCC v8: new trials by email Literature Review of Stage 0 Hypopharyngeal Carcinoma AJCC v8 trials Research Report on Stage 0 Hypopharyngeal Carcinoma AJCC v8

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Best Practice, Biospecimen Collection, Cisplatin - Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Phase 2RecruitingNRG Oncology982025-06-232026-08-17

Narrower conditions

Carcinoma (1)  ·  Hypopharyngeal Neoplasms (1)  ·  Laryngeal Neoplasms (1)  ·  Mouth Neoplasms (1)  ·  Nasopharyngeal Carcinoma (1)  ·  Oropharyngeal Neoplasms (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)  ·  Stomatitis (1)

Broader conditions

Carcinoma, Squamous Cell (1)  ·  Head and Neck Neoplasms (1)  ·  Laryngeal Diseases (1)  ·  Mouth Diseases (1)  ·  Nasopharyngeal Diseases (1)  ·  Nasopharyngeal Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Otorhinolaryngologic Diseases (1)  ·  Otorhinolaryngologic Neoplasms (1)  ·  Pharyngeal Diseases (1)  ·  Pharyngeal Neoplasms (1)  ·  Respiratory Tract Diseases (1)

Interventions

1,2-diaminocyclohexaneplatinum II citrate (1)  ·  Cisplatin (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Mn(III) meso-tetrakis(N-n-butoxyethylpyridinium-2-yl)porphyrin (1)  ·  Platinum (1)  ·  Practice Guidelines as Topic (1)  ·  Radiotherapy, Image-Guided (1)  ·  Radiotherapy, Intensity-Modulated (1)  ·  Specimen Handling (1)  ·  Standard of Care (1)

Sponsors

NRG Oncology (1)

Countries

United States (1)

Top investigators

David M Brizel (1)

NIH funding

UG1CA189867 (1)